euro adhoc: november AG
Capital measures
Shareholder´s meeting resolves
capital reduction and capital increase against contribution in kind for
financial restructuring of the company
The shareholder´s meeting has adopted the capital reduction along
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
22.05.2007
Erlangen, 22. May 2007. Today´s shareholder´s meeting of november AG has resolved all resolutions which have been proposed by the executive and the supervisory board with the needed majority. With theses resolutions, another step towards the financial restructuring of the company has been achieved. Along with the exemption from the obligation to publish and make a mandatory offer by the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht) according to § 37 Takeover Act (WpÜG), for which the presentation of a final restructuring concept, approved by an independent auditor is necessary, the further conditions precedent of the contribution contract with Biomed Beteiligungsgesellschaft mbH and Mr. Dr. Claus Müller need to be fulfilled, to legally binding proceed all measures.
The resolutions become legally binding, when raised objections will be withdrawn and no legal actions will have been taken or theses actions will not be successful.
end of announcement euro adhoc 22.05.2007 16:23:49
Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de
Branche: Biotechnology
ISIN: DE0006762909
WKN: 676290
Index: CDAX, Technologie All Share, Prime All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime
standard
Börse Berlin-Bremen / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Niedersächsische Börse zu Hannover / free trade
Bayerische Börse / free trade